Traq device test of binocular eye function in people with and without a concussion
Official title: An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury
Run by Rebiscan, Inc. · NCT07742878 · Data updated 2026-11-12
This study tests the Traq device to see how well binocular eye function works in healthy people compared with people who recently had a mild-to-moderate traumatic brain injury.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Rebiscan, Inc. Industry-sponsored |
| Locations | 1 site (Waukee, Iowa) |
| Status | Recruiting |
| Started | July 14, 2026 |
| Main results expected | October 2026 |
| Study ends | October 2026 |
| Registry record updated | August 3, 2026 |
| Trial ID | NCT07742878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 12 years or older, with no history of TBI for the normal arm, or with a history of mild-to-moderate TBI within the last six months for the post-TBI arm, who can complete study visits and assessments.
✕Probably not a fit
Patients with active eye diseases that affect retina reflectance, or those who are pregnant or breastfeeding, or currently enrolled in another device trial, may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective observational study comparing binocular ocular function between normal subjects and individuals with a recent mild-to-moderate traumatic brain injury. It uses the Traq device to measure metrics such as bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency. The study is non-randomized and non-mmasked, enrolling participants 12 years and older who meet inclusion criteria and have no exclusion conditions that would affect device signal. Data collected will help characterize how Traq measurements differ between the two populations and establish baseline measurement characteristics. The lead sponsor is Rebiscan, Inc., with Elite Eye Care/Elite Vision Therapy as the location site in Waukee, Iowa.
Why it matters
Potential benefit: If successful, the Traq device could provide objective measurements of binocular function that may aid in understanding and monitoring visual and neurological status after traumatic brain injury.
How similar studies have gone: Previous work with binocular diagnostic devices has shown promise in characterizing ocular function, but this specific Traq device study in post-TBI individuals is an early observational effort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 12 years or older at the time of enrollment. 2. Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age). 3. Willing and able to complete all required study visits and test assessments. 4. Subjects with no history of traumatic brain injury (normal arm). 5. Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm). Exclusion Criteria: 1. Concurrent participation in another drug or device clinical investigation. 2. Subject with a history of eye disease which could reduce, or limit reflected polarized light from the retina, such as corneal scarring, cataract, glaucoma, degenerative retinal conditions (e.g., age-related macular degeneration, diabetic retinopathy), or other conditions which may decrease device signal reflectance. 3. Subjects who are pregnant, planning to become pregnant, or are breastfeeding.
Where it's running
-
Elite Eye Care/Elite Vision Therapy
Waukee, Iowa, United States Recruiting
Study contacts
- Principal investigator: Heidi Bell, OD — Elite Eye Car / Elite Vision Therapy
- Study coordinator: Justin Shaka
- Email: jgshaka@rebiscan.com
- Phone: 857-600-0982
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wearable electrical stimulation to improve balance after concussion
This will test a small wearable device that gives gentle, random electrical stimulation behind the ears to see if it improves balance and walking in adults who still have symptoms after a concussion.
-
Neos™ virtual-reality test for measuring eye movements and pupil responses
This test uses a VR headset (neos™) to record where your eyes look and how your pupils react in healthy volunteers and people with eye or brain conditions.
-
Normal binocular single vision range in Singaporean adults
This study will test the normal range of binocular single vision in healthy Singaporean adults of Asian descent aged 21 to 59.
-
Mental imagery and symptom worsening in people with persistent post-concussive symptoms
This project will try short guided mental-imagery exercises to see if they trigger or worsen headaches, dizziness, or other ongoing symptoms in people with persistent post-concussive symptoms after a mild TBI.
-
Using wearable technology to improve rehabilitation for mild traumatic brain injury
This study is testing whether using wearable technology to give real-time feedback during balance exercises can help people with mild traumatic brain injuries recover better than standard rehabilitation methods.
-
Improving MRI for diagnosing anterior ischemic optic neuropathy
This study is testing new MRI techniques to see if they can help doctors better diagnose anterior ischemic optic neuropathy in adults who have vision problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.